Introduction
Pulmonary surfactant is a heterogeneous mixture containing primarily phosphatidylcholine (PC) and key proteins synthesized by pulmonary alveolar type II epithelial cells. Surfactant is enriched with dipalmitoylphosphatidylcholine (DPPC), a surface-active phospholipid that together with hydrophobic apoproteins optimizes lung structure and function. 1 Interest in the surfactant field initially accelerated with the seminal observation that deficiency of this material was etiologically linked to the neonatal respiratory distress syndrome (RDS). 2 Over the past few decades, therapy of RDS with surfactant replacement therapy has revolutionized the approach to management of RDS patients and opens promise for other pulmonary conditions associated with functional surfactant deficiencies. [3] [4] [5] The acute respiratory distress syndrome/acute lung injury (ARDS/ALI) is a surfactant-deficient state where efforts are currently underway with investigations of exogenous surfactant therapies. 6 ARDS commonly occurs secondary to bacterial sepsis resulting in critical illness and high mortality. Pseudomonas aeruginosa, a key bacterial pathogen identified in ARDS patients, has been shown to decrease surfactant DPPC levels in animal models, although the mechanisms remain unclear. [7] [8] [9] [10] [11] [12] P. aeruginosa secretes multiple virulence factors, is genetically flexible and triggers an exuberant host response. 13 Major virulence factors include alginate, exotoxins (Exo T, Exo S, Exo U and Exo Y) that emanate from a type III secretory apparatus, quorum-sensing for biofilm generation and numerous other soluble products. 13 Pseudomonal products degrade surfactant apoproteins involved in clearance of this bacterium.
14-16 P. aeruginosa release of Exo U also hydrolyzes PC-releasing lysophosphatidylcholine (LysoPC), a bioactive lipid implicated in causing lung injury. 8, [17] [18] [19] Thus, breakdown of alveolar phospholipid might be one mechanism whereby this pathogen alters surfactant levels.
Alternatively, Pseudomonas might inhibit DPPC biosynthesis by the action of inhibitory biomolecules. The organism triggers the release of cytokines such as tumor necrosis factor alpha (TNFa) and interleukin 1 beta (IL-1b) that initiate death signals to DPPC-producing type II cells upon receptor engagement. 20 Interestingly, these cytokines initiate intracellular signaling cascades resulting in the generation of LysoPC and ceramides, inhibitors that target metabolic steps within the PC biosynthetic pathway. [21] [22] [23] [24] [25] These observations suggest that efforts directed at modulating activities of enzymes within the PC synthetic pathway might prove useful in bacterial-related acute lung injury.
The biosynthesis of PC in mammals involves a series of four sequential steps: (i) cellular internalization of choline from the circulation, (ii) phosphorylation of choline to cholinephosphate by choline kinase (CK), (iii) transfer of cytidine to this choline phosphoderivativegenerating cytidine diphosphocholine (CDP-choline) by the enzyme CTP:phosphocholine cytidylyltransferase (CCT), and lastly, (iv) transfer of the phosphocholine moiety of CDP-choline to diacylglycerol by cholinephosphotransferse generating the final product, DPPC. Of these steps, the reaction catalyzed by CCT is very slow and rate regulatory and thus has served as a metabolic target to manipulate surfactant synthesis. 26 The predominant isoform of CCT in the lung is CCTa, a 367 residue enzyme that contains a catalytic core flanked by a proteolytically vulnerable amino-terminus and regulated membrane-binding and carboxyl-terminal phosphorylation domains. 27 Maneuvers designed to overexpress wild-type CCTa result in increased PC synthesis, whereas knockdown or knockout of CCTa expression result in apoptosis and embryonic lethality, respectively. [28] [29] [30] [31] CTP:phosphocholine cytidylyltransferase activity is extensively controlled by exogenous lipids, as activity is inhibited by LysoPC and ceramide. 23, 25 Aside from CCTa regulation by inhibitory lipids, we demonstrated that this enzyme is also targeted for degradation by calpains activated in response to TNFa or oxidized lipoproteins. 21, 32 Following identification of putative calpain attack sites within CCTa, we constructed a proteinase-resistant mutant form of the enzyme, termed CCT Penta , that exhibited robust in vitro activity and displayed significantly reduced sensitivity to inhibitory effects of oxidized lipoproteins on surfactant PC synthesis in a murine lung epithelial cell (MLE) line. 21 In the present study, we tested the hypothesis that overexpression of CCT Penta by adenoviral gene transfer will stimulate surfactant PC synthesis in murine lung. We demonstrate that gene transfer of this novel mutant CCTa results in sufficient expression in distal lung epithelia, resulting in increased alveolar surfactant levels. Moreover, adenoviral gene delivery of CCT Penta improved lung biophysical properties and attenuated pulmonary dysfunction observed in acute lung injury models of bacterial sepsis.
Results

Pulmonary gene transfer of a catalytically active CCTa mutant enzyme
Intratracheal administration of replication-deficient adenovirus 5 CTP:phosphocholine cytidylyltransferase (Ad5-CCT Penta ) increased lavage DPPC levels in mice in a dose-dependent manner (Figure 1 (Figure 1a) . By using 10 9 PFU/ mouse, the adenoviral vector also triggered a significant increase in CCT activity in whole lung by 50% compared to control without altering enzyme activity in the kidney (Figure 1b (inset) ). When compared to effects of the Ad5-CCT Penta construct, an empty replication-deficient adenoviral vector did not significantly alter DPPC 33 Additionally, Ad5-CCT Penta instillation in the lung did not affect mortality (data not shown). Consistent with observations on enzyme activities, Ad5-CCT Penta gene delivery also resulted in higher levels of immunoreactive CCT content (Figure 1c) .
We next analyzed the kinetics for expression of these parameters of surfactant after adenoviral-mediated CCT Penta gene transfer in vivo. Indeed, 10 9 PFU Ad5-CCT Penta infection increased DPPC levels in murine lavage by 60 and 100% versus control at 24 and 48 h of analysis, respectively (Figure 2a ), but tended to decrease levels of phosphatidylglycerol (P ¼ NS), the second major surfactant-associated phospholipid (Figure 2a , inset, P ¼ NS). However, after 72 h of infection, lavage DPPC levels decreased in mice receiving Ad5-CCT Penta versus control (Figure 2a ). Adenoviral gene transfer of Ad5-CCT Penta consistently stimulated CCT activities over the entire time course, with significant increases observed in lung at 24 and 48 h of analysis compared to matched controls ( Figure 2b ). As a control, Ad5-CCT Penta did not affect CK activity (Figure 2b , inset). Finally, because surfactant is secreted into the alveolus as a mixture consisting of phospholipids with key proteins, we assessed whether gene transfer of CCT Penta also affects levels of surfactant-associated apoproteins in alveolar lavage (Figure 2c ). Unlike expression of CCT Penta , levels of surfactant protein A (SP-A), surfactant protein B (SP-B), prosurfactant protein C (ProSP-C) and surfactant protein B (SP-D) in lavage remained unchanged after infection with the adenoviral-CCT Penta vector. Taken as a whole, these data indicate that adenoviral vectors can effectively express a modified, functional form of a key enzyme required for surfactant phospholipid biosynthesis. Further, expression of this enzyme, CCT Penta , is coupled to significantly increased levels of DPPC, the enzyme's downstream product, without alterations in steady-state levels of surfactant apoproteins. (Figure 3a) . These observations were supported by additional in vitro assays (Figures 3b and c) . In these experiments, freshly isolated mouse type II cells were infected for 18 h with Ad5-CCT Penta at a multiplicity of infection (MOI) of 5 or 12, and cellular lysates were then harvested for CCT activity ( Figure 3b ) and CCTa immunoblotting ( Figure  3c ). Indeed, consistent with the ex vivo analysis, murine type II cells infected with the adenoviral vector harboring the modified CCTa gene exhibited a dramatic increase in both CCT activity and CCTa protein content compared to uninfected cells. Thus, these studies demonstrate that Ad5-CCT Penta infection results in robust expression of the transgene in surfactant-producing type II alveolar cells.
Ad5-CCT
Ad5-CCT Penta gene transfer alters lung biophysical properties
An integrally related issue is whether biochemical changes observed with adenoviral gene transfer of the Gene transfer of surfactant enzyme in pseudomonas J Zhou et al CCTa variant is linked to alterations in lung function. Thus, we first examined if Ad5-CCT Penta expression in murine lung, which resulted in elevated alveolar DPPC levels, significantly reduces lung surface tension. In these studies, we first used LysoPC as a negative control as this lipid is known to significantly elevate surface tension. 17 We then tested the ability of LysoPC to inhibit activity of Infasurf, a commercially available calf lung surfactant preparation that served as our positive control. As expected, in vitro analysis revealed that LysoPC (3.75 mg/ml) significantly inhibited the surface-tension lowering effect of Infasurf (10 mg/ml) from 17 to 25 mN/m throughout 3 min of pulsation ( Figure 4a ). We then executed studies in four groups of mice: control mice, Ad5-CCT Penta -infected mice, mice exposed to intratracheal (i.t.) LysoPC (2.5 mg/kg) or mice given LysoPC after Ad5-CCT Penta gene transfer under optimal conditions described above. Following exposures, animals were lavaged, surfactant pellets isolated and surfactant preparations normalized to equivalent amounts of total phospholipid phosphorus before the analysis of surface tension using a pulsating bubble surfactometer. As shown in Figure 4b , surface-tension values observed in mice receiving Ad5-CCT Penta infection were significantly lower when compared to control animals. Mice administered LysoPC alone, however, exhibited high levels of surface tension. Moreover, Ad5-CCT Penta infection significantly attenuated adverse surface activities imparted by LysoPC evidenced by significantly lower surface tension (comparable to control values) relative to animals that received LysoPC alone ( Figure 4b ). As expected, instillation of LysoPC in mice significantly increased lactate dehydrogenase (LDH) activity in pulmonary lavage fluid above levels seen in alveolar samples isolated from either control mice or mice infected with Ad5-CCT Penta ; Ad5-CCT Penta infection, however, did not attenuate this cytotoxic response induced by LysoPC ( Figure 4c ). Lastly, alveolar macrophages were the predominant cell type recovered from murine alveolar lavage ( Figure 4d ) and administration of Ad5-CCT Penta or empty vector (Ad5E) did not significantly alter the cellular profile in lavage. Exposure of mice to LysoPC tended to increase neutrophil numbers, but these changes did not reach statistical significance ( Figure 4d ). As a complementary method to assess biophysical effects for Ad5-CCT Penta expression in vivo, we measured lung pressure-volume relationships (compliance) and pulmonary elastance, a function of lung stiffness (inverse of compliance) ( Figure 5 ). Mice were given diluent, Ad5-CCT Penta , LysoPC or Ad5-CCT Penta in combination with LysoPC, and subsequently intubated and mechanically ventilated with incremental amounts of positive end expiratory pressure (PEEP). First, preliminary results revealed that Ad5-CCT Penta infection at both 10 8 and 10 9 PFU revealed a tendency for an increase in quasistatic compliance evidenced by a greater DV/DP, particularly during inspiration (Figure 5a ). Importantly, in the LysoPC lung injury model, Ad5-CCT Penta gene transfer significantly improved pulmonary compliance evidenced by lowering of the pressure required to deliver the same volume compared to mice given the injurious phospholipid alone (Figure 5b ). Compared to an empty vector, Ad5-CCT Penta expression also significantly reduced LysoPC-induced increases in pulmonary elastance by B40%, but only at the lowest levels of PEEP (Figure 5c ). At higher levels of PEEP, beneficial effects of Ad5-CCT Penta expression gene transfer were obscured by positive pressure ventilation. Collectively, these observations indicate that pulmonary expression of a modified surfactant enzyme can substantially reduce physiological impairment that is triggered by an injurious phospholipid.
Ad5-CCT Penta gene transfer attenuates P. aeruginosa-associated lung injury P. aeruginosa is a well-recognized pathogen linked to acute lung injury. The PA103 organism is particularly virulent, as specific secretory products emanating from the type III secretory apparatus correlate with lung injury in an acute murine infection model of sepsis. 18, 34 We hypothesized that P. aeruginosa infection would decrease DPPC levels resulting in impaired lung mechanics, and that Ad5-CCT Penta gene transfer would rescue this phenotype. Indeed, mice infected with P. aeruginosa generally exhibited a dose-dependent (Figure 6a , Po0.05 versus control). Further, Ad-CCT Penta gene delivery before infection with the pathogen significantly reduced elastance compared to mice given P. aeruginosa alone (Figure 6b ). Mice given P. aeruginosa with Ad-CCT Penta exhibited a small but significant increase in survival time versus the bacterium alone (Figure 6c) .
To examine the mechanisms whereby bacterial infection reduces surfactant, murine lung epithelial cells were infected with P. aeruginosa. P. aeruginosa significantly decreased CCT activity and immunoreactive CCTa content in cells within 1 h (Figure 7a and b) . Real-time polymerase chain reaction (PCR) analysis revealed that within this time frame, there was no effect of the organism on steady-state levels of CCTa mRNA (data not shown). P. aeruginosa activated calpain at 30 min and significantly by 60 min (Figure 7c) . Moreover, MLE cells transfected with either a plasmid encoding the endogenous calpain inhibitor, calpastatin or CCT Penta blocked P. aeruginosa-induced decreases in levels of the surfactant enzyme (Figure 7d) . The results suggest that P. aeruginosa decreases DPPC synthesis, in part, by calpain-mediated degradation of CCTa.
Discussion
This study demonstrates that adenoviral gene transfer of a mutant form of the regulatory enzyme, CCTa, attenuates the deleterious effects of P. aeruginosa infection by significantly increasing the biosynthesis of surfactant DPPC in murine lung. Moreover, these biochemical effects seen after gene transfer were coupled to an increase in alveolar DPPC and improvement in pulmonary mechanics in animal models of sepsis-induced acute pulmonary injury. Specifically, by successfully expressing CCT Penta in alveolar type II epithelia, we achieved increases in alveolar DPPC levels that were sufficient to reduce alveolar surface tension and improve pressurevolume relationships in native lung and lungs infected with P. aeruginosa. Although significant obstacles still limit the translation of such findings for therapeutic gene Gene transfer of surfactant enzyme in pseudomonas J Zhou et al transfer in humans, the results demonstrate the feasibility of delivering a lipogenic enzyme to distal lung epithelia in models where functional surfactant deficiencies play an important pathophysiological role. We selected CCT Penta , rather than wild-type CCTa, as our transgene because of its relative in vitro protein stability. 21 Our prior data indicate that TNFa and oxidized lipoproteins, factors released in acute lung injury, activate neutral proteinases (calpains) that readily cleave wild-type CCTa within the amino-terminus and near a carboxyl-terminal hinge region of the enzyme. 21 Thus, we packaged a proteolytically resistant CCTa variant into a replication-deficient adenoviral vector where amino acids flanking the calpain cleavage sites were mutated to nonhydrolyzable residues.
Intratracheal adenoviral gene transfer of CCT Penta was optimized at 10 9 PFU/mouse with maximal effects on surfactant seen 48 h after infection consistent with effects of other transgenes. 35, 36 In vivo expression of the CCT Penta construct stimulated DPPC synthesis within type II cells without altering levels of phosphatidylglycerol or surfactant proteins. Although adenoviral vectors might disrupt surfactant protein expression, this was not observed after CCT Penta gene transfer. 37 Deficiency of surfactant proteins impairs pulmonary mechanics; however, lung function may be more directly related to alveolar DPPC content. [38] [39] [40] Artificial exogenous surfactants devoid of apoproteins also exert beneficial effects therapeutically indicating that manipulation of surfactant lipids can selectively attenuate lung injury. 41 As a whole, the data suggest that surfactant apoprotein availability is not limiting in this system.
To our knowledge, these studies represent the first demonstration that gene transfer of an enzyme can improve pulmonary mechanics. Other work shows that replication-deficient adenoviral vectors efficiently deliver a variety of proteins to alveolar lining cells, resulting in improved pulmonary hemodynamics, histopathology, or reduced inflammation or edema formation, but effects on lung function were not tested. 36, [42] [43] [44] [45] Impairment of pulmonary mechanics is observed when alveolar surfactant levels are reduced during inflammation as seen in sepsis-induced lung injury. In the most severe form of surfactant deficiency, manifestations include a syndrome of high surface-tension pulmonary edema characterized by reduced compliance and increased elastance. 46 Elastance represents the applied pressure that is required to achieve an incremental increase in lung volume; it is more sensitive to structural changes in the distal lung, such as atelectasis, which may result from surfactant Gene transfer of surfactant enzyme in pseudomonas J Zhou et al deficiency. Increasing the level of PEEP overcomes these structural abnormalities and can ameliorate factors in the distal lung that increase elastance (such as atelectasis).
Lysophosphatidylcholine was used because this lipid reliably produces lung injury in vivo, elevates surface tension and inhibits CCT activity. 17, 25 Indeed, adenoviral gene transfer of CCT Penta in mice receiving LysoPC resulted in lower levels of elastance versus mice injured with LysoPC at low levels of PEEP, consistent with improvement of distal atelectasis. These data are highly consistent with an increase in distal lung surface tension in the LysoPC-treated mice, an effect partially overcome by gene delivery of CCT Penta .
To examine effects of gene transfer of CCT Penta on a more biologically relevant model, we pursued studies of bacterial infection. P. aeruginosa elaborates multiple deleterious products for lung epithelia resulting in reduced surfactant function. 9 In this study, we used P. aeruginosa (PA103), a highly virulent species of bacterium that produces acute, lethal septic lung injury. Infection with PA103 in mice, however, may not necessarily mimic the lung injury syndrome caused by P. aeruginosa clinical isolates recovered from ARDS patients. PA103 virulence is attributed to its ability to elaborate several effector proteins comprising the type III-dependent secretion pathway. 47 The most potent cytotoxic product of the type III pathway is Exo U, a protein that exhibits phospholipase A 2 -like activity responsible for LysoPC generation. 47, 48 LysoPC has also been shown to activate calpains. 49 A new finding here is that P. aeruginosa activated calpains and degraded the CCTa enzyme via a calpain-dependent mechanism as effects were overcome after expression of calpastatin. The use of Pseudomonas therefore seemed to provide a suitable model system to test in vivo activity of CCT Penta and surfactant synthesis. Indeed, PA103 infection significantly reduced alveolar DPPC levels and impaired lung mechanics. In comparison, the PA103DexoU variant displayed less inhibition evidenced by higher surfactant levels, suggesting that Exo U at least partly contributes to effects of P. aeruginosa on DPPC metabolism. These deleterious effects by the pathogen on surfactant were partly blocked by adenoviral gene delivery of the CCTa mutant. The data do not exclude Exo U-directed hydrolysis of DPPC, but reveal that P. aeruginosa inhibition of surfactant production via degradation of CCTa is also mechanistically relevant. It is conceivable that CCT Penta gene transfer provides a better surfactant barrier for type II cells against reactive products released by P. aeruginosa rather than reducing the bacterial load by enhancing surfactant apoprotein-mediated opsonic activity. Figure 6 Replication-deficient adenovirus 5 CTP:phosphocholine cytidylyltransferase (Ad5-CCT Penta ) gene transfer in P. aeruginosa infection. (a) Mice were given diluent (control) or were infected with P. aeruginosa (PA103) at various colony-forming unit (CFU)/ mouse or a PA103 mutant lacking Exo U (1 Â 10 7 CFU/mouse, PA103DExo U) and were euthanized 1 h later. In some studies, mice were given Ad5-CCT as in Figure 1 Finally, effects of adenoviral gene transfer of CCT Penta on surfactant levels were not sustained. Despite increases in CCTa expression, there was a decrease in DPPC in alveolar lavage by 72 h after infection (Figure 2) . We suspect that this finding is likely attributed to increased surfactant degradation mediated by secretory phospholipases or from accelerated uptake of phospholipid by alveolar macrophages. The results resemble findings in CCTa-overexpressing transgenic mice where only modest increases in alveolar surfactant were seen, despite high-level CCTa expression in lung epithelia. 28 Conditional upregulation of CCTa in nonepithelial cell cultures also increases PC synthesis, but at the same time triggers PC degradation via phospholipase activation. 51 It is possible that future studies of gene therapy could entail the delivery of CCTa variants in combination with exogenous PCs that are modified to resist activated phospholipases by virulent bacteria. 52 Enhanced uptake of surfactant by alveolar macrophages, however, may be more problematic. This underscores the need to increase understanding of the molecular mechanisms for recycling of DPPC in these cells.
Materials and methods
Materials
Hite's medium and Dubecco's modified Eagle's medium (DMEM) were obtained from the University of Iowa Tissue Culture Facility (Iowa City, IA, USA). The MLE-12 cell line was obtained from American Type Culture Collection (Manassas, VA, USA). Radiochemicals including [methyl- 3 H]choline chloride were purchased from American Radiolabeled Chemicals (St Louis, MO, USA). Nitrocellulose membranes were obtained from Millipore (Bedford, MA, USA). The enhanced chemiluminescence (ECL) Western blotting detection system was from Pierce Biotechnology (Rockford, IL, USA). Anti-CCTa rabbit polyclonal antiserum to synthetic peptide was generated by Covance Research Products Inc. (Richmond, CA, USA). The polyclonal antibody to b-actin was purchased from R&D Systems (Minneapolis, MN, USA). The SP-A, SP-B, ProSP-C and SP-D antibodies were from Chemicon (Temecula, CA, USA), and Advantage cDNA polymerase was from Clontech (Palo Alto, CA, USA). The pOP13-JHCPIS (calpastatin inhibitory domain fragment) plasmid was a gift from Dr Neil Forsberg, Oregon State University, Corvallis, OR, USA. 53 The Geneclean2 Kit was obtained from Bio101 (Carlsbad, CA, USA). The pCR4-TOPO plasmid was obtained from Invitrogen (Carlsbad, CA, USA). Infasurf was obtained from Forest Pharmaceuticals (St Louis, MO, USA). Phospholipids including LysoPC and the LDH kit were obtained from Sigma (St Louis, MO, USA). The calpain activity assay kit was from Calbiochem (San Diego, CA, USA). P. aeruginosa (PA103) and a mutant strain lacking a functional Exo U was obtained from Dr Timothy L Yahr (University of Iowa, Iowa City, IA, USA). 34, 47 The All DNA sequencing was performed by the University of Iowa DNA Core Facility, Iowa City, IA, USA.
Construction of a recombinant adenoviral vector expressing a mutant surfactant enzyme CCT Penta
A cDNA fragment encoding a rat CCT mutant, termed CCT Penta , that confers partial proteinase resistance to Gene transfer of surfactant enzyme in pseudomonas J Zhou et al calpains has been described previously. 21 Briefly, CCT Penta was generated using CCT Penta plasmid as a template, using the sense primer: 5 0 -ggatccatggatgcacagagttcagc-3 0 and the antisense primer: 5 0 -tctagattagtcctcttcatcctcgctg-3 0 in a two-step PCR amplification procedure using Advantage cDNA polymerase as described previously. 21 The B1100 bp CCT Penta was purified using the Geneclean2 kit, cloned into pCR4-TOPO, and plasmids minipreps verified by DNA sequencing. Selected clones were digested by BamH1 and Xba1, purified and ligated into a shuttle plasmid, VQ Ad5CMV K-NpA (ViraQuest, North liberty, IA, USA) previously digested with the same restriction enzymes. The resultant plasmid, termed Ad5-CCT Penta , was then packaged into an adenoviral vector by ViraQuest resulting in the recombinant replication-deficient Ad5-CCT Penta vector that was propagated and titered in a permissive human 293 cell line.
Animals and cell culture
For in vivo gene delivery, male C57BL/6J mice, 6-8 weeks old, weighing 20-25 g (Jackson Laboratories, Bar Harbor, ME, USA) were deeply anesthetized with ketamine (80-100 mg/kg intraperitoneally (i.p.)) and xylazine (10 mg/ kg i.p.). Following adequate anesthesia, the larynx was well visualized under a fiber-optic light source before endotracheal intubation with a 3/4 00 24-G plastic catheter. Replication-deficient adenovirus alone or Ad5-CCT Penta (10 7 -10 9 PFU in 50 ml of 10 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.1% bovine serum albumin), or diluent was instilled i.t. on day 1, after which animals were allowed to recover for 24-72 h. Following recovery, mice were euthanized with pentobarbital (150 mg/i.p.) and used for biochemical or biophysical measurements. In some studies, mice were administered LysoPC (2.5 mg/ kg i.t.), P. aeruginosa (PA103, 10 1 -10 7 CFU i.t./mouse) or a mutant P. aeruginosa lacking Exo U (PA103DexoU, 10 7 CFU i.t./mouse) 34 for 1 h before euthanasia. Survival time was measured using a standard clock after instilling organisms with end points determined by cessation of visible respirations. Lungs were lavaged, lavage cells, surfactant pellets were isolated as described previously 54 and lung tissue was homogenized in buffer A (containing 150 mM NaCl, 50 mM Tris, 1 mM ethylenediaminetetraaceticacid, 2 mM dithiothreitol and 0.025 sodium azide). Lavage fluid was centrifuged to pellet cells and total cell counts were determined using a hemocytometer. Differential cell counts were assessed on cytologic preparations obtained by cytocentrifugation of diluted fluid. Slides were stained with hematoxylin and eosin. Cells were identified as macrophages, neutrophils and eosinophils, and expressed as the percentage of absolute numbers from total cell counts.
In separate studies, lungs were used for isolation of murine primary alveolar type II epithelial cells as described. The purity of type II cells was 495% in our laboratory as determined by tannic acid staining. 55 Cells were cultured overnight in DMEM containing 2% carbon-stripped fetal bovine serum (FBS) for further analysis the next day. Murine lung epithelial cells were cultured in 60 or 100 mm dishes to B80% confluence in Hite's medium with 2% FBS at 371C in atmosphere containing 5% CO 2 . Before stimulation, cells were rinsed in serum-free medium and exposed to P. aeruginosa (PA103, MOI 1-20/dish) for up to 1 h. All experimental procedures were performed in accordance with the protocols approved by the University of Iowa Animal Care and Use Committee.
Quantitative analysis of alveolar dipalmitoylphosphatidylcholine
The levels of DPPC in murine lavage were quantitatively measured by using the phosphorus assay following lipid extraction, treatment with osmium tetroxide and resolution of individual phospholipids using thin-layer chromatography as described previously. 32 
Phospholipid synthesis
Phosphatidylcholine biosynthesis was measured as the rate of incorporation of [methyl-H] choline incorporation into PC as described. 27 Other phospholipids were assayed similarly using [ CTP:phosphocholine cytidylyltransferase activity CTP:phosphocholine cytidylyltransferase activities were determined by measuring the rate of incorporation of [methyl- 14 C]phosphocholine into CDP-choline using a charcoal extraction method. 54 CTP:phosphocholine cytidylyltransferase activities were determined without the addition of exogenous lipid activator in the reaction mixture. Choline kinase activities were also assayed as described. 54 
Immunoblot analysis
Immunoblotting was performed using polyclonal antibodies to CCT, b-actin or surfactant proteins SP-A, SP-B, ProSP-C and SP-D as described. 32 For these studies, equal amounts of cellular or whole-lung protein was loaded on 10% sodium dodecyl sulfate-polyacrylamide gels and transferred to a nitrocellulose membrane. Immunoreactive products were detected using an ECL Western blotting detection system. Dilution factors of all primary antibodies used for probing membranes was 1:1000.
Surface-tension analysis
Dynamic surface-tension analysis was performed by using a pulsating bubble surfactometer (General Transco, Lancaster, NY, USA). 56 The bubble was pulsated at 371C at a rate of 20 cycles/min for up to 3 min. 57 A commercially available surfactant isolated from calf lung (Infasurf, 10 mg/ml) was used to evaluate potential inhibitors of surfactant function. Before assay on the surfactometer, all murine lavage surfactant preparations were adjusted to final concentrations of 10 mg/ml phospholipid and 1.6 mM CaCl 2 in phosphate-buffered saline (PBS; 140 mM NaCl, 5 mM CaCl 2 , pH 7.0). Stock LysoPC was suspended in PBS and adjusted to a final concentration of 3.75 mg/ml alone or in combination with Infasurf.
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Respiratory compliance and elastance
Mice were anesthetized with ketamine and xylazine, a tracheostomy was performed and a metal 1.2 mm (internal diameter) tracheal cannula was inserted and tied firmly into place. An electrocardiograph tracing was monitored to ascertain any adverse effects of the ventilatory maneuvers. The mice were placed on a FlexiVent (Scireq, Montreal, Quebec, Canada) ventilator using a module (Module 1) with a maximal stroke volume of 0.9 ml. Quasi-static ventilation was initiated using a tidal volume of 8.5 ml/kg and a rate of 150. The mice were paralyzed with 1 mg/kg of pancuronium bromide and additional doses were given if there was evidence of muscular activity. The PEEP was adjusted to 1, 3, 5, 7, 9 and 11 cm PEEP before a series of maneuvers that were performed by the ventilator. First, one repetition of a quasi-static pressure-volume maneuver delivered 29.5 ml/kg of air in 4.2 ml/kg increments with a pressure determination at 1 s after each increment was delivered. Then, a sequence of perturbations was introduced at 30 s intervals that included a 6.0 ml/kg tidal breath (snap-shot) followed 9 s later by a 2 s respiratory pause and then a series of oscillations from 0.2 to 20 Hz that were delivered over 8 s (prime-8). Ventilation was resumed after 1 s and continued for 10 s. This sequence was repeated two more times at each level of PEEP. The PEEP was adjusted to the next level and the sequence of the pressure-volume determination followed by three alternating measurements of the snap-shot and prime-8 until the maximal PEEP was achieved. The pressure in the ventilator cylinder that was used to deliver the breath and the volume of the breath were measured and used to calculate the total respiratory resistance and elastance, the airway-specific resistance, and the elastance and tissue resistance of the peripheral lung. Calculations were performed using the standard algorithms that were included in the FlexiVent Version 4 software program.
Lactate dehydrogenase and calpain activities
Lactate dehydrogenase was measured as an index of lung injury. Lavages were isolated and supernatants obtained by centrifugation at 30 000 r.p.m. for 2 h. Lactate dehydrogenase activity was measured using 0.3 ml of lavage supernatants using the LDH Kit as per the manufacturer's instructions. This method detects loss of nicotinamide adenine dinucleotide (reduced form) via absorbance at 340 nm in a linear range over time. Calpain activity was assayed in cell lysates as per the manufacturer's instructions using a fluorogenic substrate assay kit and microplate reader with the detection of fluorescence at wavelengths of excitation at B360 nm and emission at B460 nm.
Transfectional analysis
For expression of CCTa plasmids or the calpastatin plasmid, MLE cells were transfected for 24 h (10 mg/ 60 mm dish) with test plasmids. After transfections, cells were transferred to serum-free medium containing Pseudomonas for various times before harvesting of cells for biochemical analysis.
Statistical analysis
All data were analyzed using statistical software SPSS 11. 
